Biocon Ltd on Monday said it has launched its diabetes and chronic, Liraglutide, in the Netherlands through its distribution partner, Pharmamedic BV. The drug-device combination will be marketed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback